These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 3306479)

  • 21. α-Ketoglutaramate: an overlooked metabolite of glutamine and a biomarker for hepatic encephalopathy and inborn errors of the urea cycle.
    Cooper AJ; Kuhara T
    Metab Brain Dis; 2014 Dec; 29(4):991-1006. PubMed ID: 24234505
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development of an experimental rat model of hyperammonemic encephalopathy and evaluation of the effects of rifaximin.
    Tamaoki S; Suzuki H; Okada M; Fukui N; Isobe M; Saito T
    Eur J Pharmacol; 2016 May; 779():168-76. PubMed ID: 26980242
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ammonia and Its Role in the Pathogenesis of Hepatic Encephalopathy.
    Parekh PJ; Balart LA
    Clin Liver Dis; 2015 Aug; 19(3):529-37. PubMed ID: 26195206
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Glutamine synthetase in brain: effect of ammonia.
    Suárez I; Bodega G; Fernández B
    Neurochem Int; 2002; 41(2-3):123-42. PubMed ID: 12020613
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ammonia and amino acid profiles in liver cirrhosis: effects of variables leading to hepatic encephalopathy.
    Holecek M
    Nutrition; 2015 Jan; 31(1):14-20. PubMed ID: 25220875
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multifactorial Effects on Different Types of Brain Cells Contribute to Ammonia Toxicity.
    Hertz L; Song D; Peng L; Chen Y
    Neurochem Res; 2017 Mar; 42(3):721-736. PubMed ID: 27286679
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pathogenesis of hepatic encephalopathy: update on molecular mechanisms.
    Butterworth RF
    Indian J Gastroenterol; 2003 Dec; 22 Suppl 2():S11-6. PubMed ID: 15025246
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Memantine, a noncompetitive NMDA receptor antagonist improves hyperammonemia-induced encephalopathy and acute hepatic encephalopathy in rats.
    Vogels BA; Maas MA; Daalhuisen J; Quack G; Chamuleau RA
    Hepatology; 1997 Apr; 25(4):820-7. PubMed ID: 9096582
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Protective effect of L-carnitine in ammonia-precipitated encephalopathy in the portacaval shunted rat.
    Therrien G; Rose C; Butterworth J; Butterworth RF
    Hepatology; 1997 Mar; 25(3):551-6. PubMed ID: 9049197
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pathogenesis of hepatic encephalopathy and brain edema in acute liver failure: role of glutamine redefined.
    Desjardins P; Du T; Jiang W; Peng L; Butterworth RF
    Neurochem Int; 2012 Jun; 60(7):690-6. PubMed ID: 22382077
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of sodium benzoate on cerebral and hepatic energy metabolites in spf mice with congenital hyperammonemia.
    Ratnakumari L; Qureshi IA; Butterworth RF
    Biochem Pharmacol; 1993 Jan; 45(1):137-46. PubMed ID: 8424807
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Amino acid changes in regions of the CNS in relation to function in experimental portal-systemic encephalopathy.
    Giguère JF; Butterworth RF
    Neurochem Res; 1984 Sep; 9(9):1309-21. PubMed ID: 6150451
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gut ammonia production and its modulation.
    Romero-Gómez M; Jover M; Galán JJ; Ruiz A
    Metab Brain Dis; 2009 Mar; 24(1):147-57. PubMed ID: 19067141
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metabolic encephalopathy: mechanisms affecting limbic function.
    Lockwood AH
    Tohoku J Exp Med; 1990 Aug; 161 Suppl():203-11. PubMed ID: 1964512
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cerebral ammonia metabolism in normal and hyperammonemic rats.
    Cooper AJ; Lai JC
    Neurochem Pathol; 1987; 6(1-2):67-95. PubMed ID: 2888066
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of oral L-ornithine L-aspartate in cirrhotic patients with hyperammonemic hepatic encephalopathy.
    Blanco Vela CI; Poo Ramírez JL
    Ann Hepatol; 2011 Jun; 10 Suppl 2():S55-9. PubMed ID: 22228883
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effects of ammonia and portal-systemic shunting on brain metabolism, neurotransmission and intracranial hypertension in hyperammonaemia-induced encephalopathy.
    Vogels BA; van Steynen B; Maas MA; Jörning GG; Chamuleau RA
    J Hepatol; 1997 Feb; 26(2):387-95. PubMed ID: 9059962
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ammonia-lowering strategies for the treatment of hepatic encephalopathy.
    Rose CF
    Clin Pharmacol Ther; 2012 Sep; 92(3):321-31. PubMed ID: 22871998
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mechanisms of brain edema in acute liver failure and impact of novel therapeutic interventions.
    Vaquero J; Butterworth RF
    Neurol Res; 2007 Oct; 29(7):683-90. PubMed ID: 18173908
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Brain ion and amino acid contents during edema development in hepatic encephalopathy.
    Hilgier W; Olson JE
    J Neurochem; 1994 Jan; 62(1):197-204. PubMed ID: 8263520
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.